Skip to main content
    I

    InfuSystems Holdings Inc (INFU)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • AMEX

    $14.81
    +0.09 (+0.61%)

    Market Cap: $294.89M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    InfuSystems Holdings Inc (INFU) P/E Ratio & Valuation History

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    InfuSystems Holdings (INFU) trades at 29.6x trailing earnings and 2.0x sales. Its P/E of 29.6x is below its 5-year median of 96.1x. Its forward P/E is 30.0x. The median P/E across 4 similar companies is 23.9x.

    Current Multiples

    Its forward P/E is above its trailing P/E, which implies earnings per share about 1.3% lower over the next year. Its free cash flow yield is 8.4%.

    MultipleValue
    P/E (trailing)29.6x
    Forward P/E30.0x
    Price to sales2.0x
    Price to book4.6x
    EV/EBITDA11.2x
    Price to FCF11.9x
    EV/FCF12.4x
    PEG1.7
    FCF yield8.4%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/S is 42.9% above 1.4x and its P/B is 21.1% above 3.8x.

    MultipleCurrent5-year median10-year median
    P/E29.6x96.1xN/A
    P/S2.0x1.5x1.4x
    P/B4.6x3.5x3.8x
    Medians of month-end values through Oct 2026: 56 to 60 months (5-year) and 120 months (10-year).

    Valuation History

    Over the 7 of the 10 year ends shown that have a P/E, its P/E ranged from 17.9x in 2025 to 868.0x in 2022. 2025 was the lowest of those years.

    Year endPriceP/EP/SP/B
    2025$8.9717.9x1.3x3.3x
    2024$8.4546.8x1.3x3.2x
    2023$10.54113.0x1.8x4.4x
    2022$8.68868.0x1.6x3.9x
    2021$17.03212.9x3.5x7.8x
    2020$18.7823.2x3.9x10.0x
    2019$8.53142.2x2.1x8.1x
    2018$3.44N/A1.1x3.3x
    2017$2.30N/A0.7x1.7x
    2016$2.55N/A0.8x1.1x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About INFU

    What is INFU's forward P/E ratio?

    InfuSystems Holdings has a forward P/E ratio of 30.0x.

    Is INFU stock overvalued?

    GNG's valuation label for INFU is Fairly valued. Its P/E of 29.6x compares with a median of 23.9x across 4 similar companies.

    What is INFU's price to sales ratio?

    InfuSystems Holdings has a price to sales ratio of 2.0x.

    What is InfuSystems Holdings's average P/E ratio over 5 years?

    InfuSystems Holdings's median P/E over the last 5 years is 96.1x, from 56 month-end values through Oct 2026.

    What is INFU's PEG ratio?

    InfuSystems Holdings has a PEG ratio of 1.7.